{"hands_on_practices": [{"introduction": "Understanding the function of an ion channel like the nAChR begins with predicting its electrical behavior based on its intrinsic properties and the ionic environment. This exercise challenges you to apply the foundational Goldman-Hodgkin-Katz (GHK) equation to calculate the channel's reversal potential, which is determined by ion concentrations and relative permeabilities. By then using the channel's conductance, you can calculate the precise current that flows at a given membrane potential, linking fundamental biophysical theory to a measurable outcome [@problem_id:2346541].", "problem": "A team of neuroscientists is investigating the properties of a neuronal nicotinic acetylcholine receptor (nAChR), a ligand-gated ion channel. In its wild-type form, this channel is permeable to both sodium ($Na^{+}$) and potassium ($K^{+}$) ions. The scientists create a specific mutation by replacing a highly conserved leucine residue in the pore-lining M2 transmembrane helix with a more polar threonine residue. They hypothesize this change will alter the channel's ion selectivity.\n\nAssume the experiment is conducted at a physiological temperature of $37.0^\\circ\\text{C}$. The extracellular concentrations are $[Na^{+}]_{out} = 145 \\text{ mM}$ and $[K^{+}]_{out} = 5.0 \\text{ mM}$. The intracellular concentrations are $[Na^{+}]_{in} = 10.0 \\text{ mM}$ and $[K^{+}]_{in} = 140 \\text{ mM}$.\n\nThe mutation alters the relative permeability of the channel, changing the permeability ratio of sodium to potassium ($P_{Na}/P_K$) from its wild-type value to a new value of $P_{Na}/P_K = 1.35$. The single-channel conductance of this mutant receptor is measured to be $g = 48.0 \\text{ pS}$.\n\nCalculate the net single-channel current that would be measured through a single mutant nAChR channel when the neuron's membrane potential is held constant at $V_m = -65.0 \\text{ mV}$. Use the convention that inward current (flow of positive charge into the cell) is negative.\n\nFor your calculations, use the following constants:\n- Faraday constant, $F = 96485 \\text{ C/mol}$\n- Ideal gas constant, $R = 8.314 \\text{ J/(mol}\\cdot\\text{K)}$\n\nExpress your answer in picoamperes (pA), rounded to three significant figures.", "solution": "To find the single-channel current at a fixed membrane potential for a channel permeable to $Na^{+}$ and $K^{+}$ with a given permeability ratio, proceed as follows.\n\nFirst compute the reversal potential using the Goldman-Hodgkin-Katz voltage equation for monovalent cations:\n$$\nE_{\\text{rev}}=\\frac{RT}{F}\\ln\\left(\\frac{P_{K}[K^{+}]_{\\text{out}}+P_{Na}[Na^{+}]_{\\text{out}}}{P_{K}[K^{+}]_{\\text{in}}+P_{Na}[Na^{+}]_{\\text{in}}}\\right).\n$$\nWith the ratio $\\alpha=\\frac{P_{Na}}{P_{K}}=1.35$, set $P_{Na}=\\alpha P_{K}$ and cancel $P_{K}$:\n$$\nE_{\\text{rev}}=\\frac{RT}{F}\\ln\\left(\\frac{[K^{+}]_{\\text{out}}+\\alpha[Na^{+}]_{\\text{out}}}{[K^{+}]_{\\text{in}}+\\alpha[Na^{+}]_{\\text{in}}}\\right).\n$$\nSubstitute the concentrations and temperature. Convert temperature to Kelvin:\n$$\nT=273.15+37.0=310.15\\ \\text{K},\n$$\nand compute the concentration ratio:\n$$\n\\frac{[K^{+}]_{\\text{out}}+\\alpha[Na^{+}]_{\\text{out}}}{[K^{+}]_{\\text{in}}+\\alpha[Na^{+}]_{\\text{in}}}\n=\\frac{5.0+1.35\\times 145}{140+1.35\\times 10}\n=\\frac{5.0+195.75}{140+13.5}\n=\\frac{200.75}{153.5}\\approx 1.3078176.\n$$\nUsing the given constants $R=8.314\\ \\text{J/(mol}\\cdot\\text{K)}$ and $F=96485\\ \\text{C/mol}$:\n$$\n\\frac{RT}{F}=\\frac{8.314\\ \\text{J/(mol}\\cdot\\text{K)}\\times 310.15\\ \\text{K}}{96485\\ \\text{C/mol}}\\ \\approx 0.026717\\ \\text{V},\n$$\nand\n$$\n\\ln(1.3078176)\\approx 0.26834,\n$$\nso\n$$\nE_{\\text{rev}}\\approx \\left(0.026717\\ \\text{V}\\right)\\left(0.26834\\right)\\approx 0.007168\\ \\text{V}=7.168\\ \\text{mV}.\n$$\n\nFor an ohmic single channel with conductance $g$, the current at membrane potential $V_{m}$ is\n$$\nI=g\\left(V_{m}-E_{\\text{rev}}\\right).\n$$\nWith $g=48.0\\ \\text{pS}=48.0\\times 10^{-12}\\ \\text{S}$ and $V_{m}=-65.0\\ \\text{mV}=-0.0650\\ \\text{V}$,\n$$\nV_{m}-E_{\\text{rev}}=-0.0650\\ \\text{V}-0.007168\\ \\text{V}=-0.072168\\ \\text{V},\n$$\nso\n$$\nI=\\left(48.0\\times 10^{-12}\\ \\text{S}\\right)\\left(-0.072168\\ \\text{V}\\right)\\approx -3.464\\times 10^{-12}\\ \\text{A}=-3.464\\ \\text{pA}.\n$$\nRounding to three significant figures and using the convention that inward current is negative gives $-3.46\\ \\text{pA}$.", "answer": "$$\\boxed{-3.46}$$", "id": "2346541"}, {"introduction": "While theoretical models allow us to predict channel behavior, experimental validation is the cornerstone of neuroscience. This practice simulates a common electrophysiology experiment where you are given current measurements at different membrane voltages. Your task is to analyze this current-voltage ($I$-$V$) data to determine the reversal potential ($E_{rev}$), the specific voltage at which there is no net flow of ions through the channel [@problem_id:2346537].", "problem": "A neurobiologist is investigating a newly discovered synapse in the central nervous system. Using the whole-cell patch-clamp technique, the researcher records the electrical currents flowing through the postsynaptic membrane while holding the membrane potential at various fixed levels. After applying a saturating concentration of acetylcholine to activate all available postsynaptic nicotinic acetylcholine receptors (nAChR), the following steady-state current amplitudes are measured at different holding potentials. The data assumes that nAChRs are the only channels activated by this protocol and that their current-voltage relationship is linear in this range.\n\nThe experimental data are as follows:\n- At a holding potential of -70 mV, the measured current is -130 pA.\n- At a holding potential of -40 mV, the measured current is -70 pA.\n- At a holding potential of -10 mV, the measured current is -10 pA.\n- At a holding potential of +20 mV, the measured current is +50 pA.\n\nBased on this data, what is the reversal potential ($E_{rev}$) for these nAChR-mediated currents?\n\nA. -10 mV\n\nB. 0 mV\n\nC. -5 mV\n\nD. +5 mV\n\nE. -40 mV", "solution": "The current-voltage relationship for a population of identical ion channels that behave ohmically is linear and can be written as\n$$\nI = g\\,(V - E_{rev}),\n$$\nwhere $I$ is the current, $V$ is the membrane potential (holding potential), $g$ is the conductance (slope of the $I$-$V$ relation), and $E_{rev}$ is the reversal potential (the voltage at which $I=0$).\n\nUsing two data points, for example $(V_{1}, I_{1}) = (-10 \\text{ mV}, -10 \\text{ pA})$ and $(V_{2}, I_{2}) = (20 \\text{ mV}, 50 \\text{ pA})$, compute the slope (conductance):\n$$\ng = \\frac{I_{2} - I_{1}}{V_{2} - V_{1}} = \\frac{50 \\text{ pA} - (-10 \\text{ pA})}{20 \\text{ mV} - (-10 \\text{ mV})} = \\frac{60 \\text{ pA}}{30 \\text{ mV}} = 2 \\text{ pA/mV}.\n$$\nSubstitute $(V_{1}, I_{1})$ into the linear relation to solve for $E_{rev}$:\n$$\nI_{1} = g\\,(V_{1} - E_{rev}) \\;\\;\\Rightarrow\\;\\; -10 \\text{ pA} = 2 \\text{ pA/mV}\\,\\left(-10 \\text{ mV} - E_{rev}\\right).\n$$\nDivide both sides by $2 \\text{ pA/mV}$:\n$$\n-5 \\text{ mV} = -10 \\text{ mV} - E_{rev} \\;\\;\\Rightarrow\\;\\; E_{rev} = -10 \\text{ mV} + 5 \\text{ mV} = -5 \\text{ mV}.\n$$\nVerification with other points:\n- At $V=-40 \\text{ mV}$, $I = 2 \\text{ pA/mV}\\,(-40 \\text{ mV} - (-5 \\text{ mV})) = 2 \\times (-35) \\text{ pA} = -70 \\text{ pA}$, matches.\n- At $V=-70 \\text{ mV}$, $I = 2 \\times (-65) \\text{ pA} = -130 \\text{ pA}$, matches.\n\nTherefore, the reversal potential is $-5 \\text{ mV}$, corresponding to option C.", "answer": "$$\\boxed{C}$$", "id": "2346537"}, {"introduction": "Beyond its intrinsic properties, the function of the nAChR is profoundly influenced by pharmacological agents that can inhibit its activity. This problem presents a classic pharmacological puzzle: distinguishing between different types of channel blockers based on their experimental effects. By analyzing how the channel's response to acetylcholine is altered in the presence of two different drugs, you will learn to identify the distinct mechanisms of competitive and non-competitive antagonism [@problem_id:2346549].", "problem": "An electrophysiologist is investigating the properties of a specific subtype of nicotinic acetylcholine receptors (nAChRs) expressed on a cultured neuron. The experiment utilizes the whole-cell patch-clamp technique to measure the total inward ion current flowing through these channels when activated by their natural agonist, acetylcholine (ACh). The study aims to characterize the mechanism of two unknown pharmacological agents, Drug X and Drug Y.\n\nThe following observations are recorded:\n\n1.  **Control:** The application of a standard concentration, $C_{ACh}$, of acetylcholine to the neuron reliably induces a maximal inward current, denoted as $I_{max}$.\n2.  **Drug X Trial:** The neuron is first incubated with Drug X. When the standard concentration $C_{ACh}$ of acetylcholine is subsequently applied, the resulting inward current is significantly less than $I_{max}$. However, when the experiment is repeated with a much higher concentration of acetylcholine ($100 \\times C_{ACh}$), the measured inward current successfully recovers to the original maximal value, $I_{max}$. When applied alone, Drug X produces no measurable current.\n3.  **Drug Y Trial:** The neuron is first incubated with Drug Y. Similar to the previous trial, the application of the standard ACh concentration $C_{ACh}$ results in an inward current significantly less than $I_{max}$. In stark contrast to the trial with Drug X, even when the acetylcholine concentration is increased to $100 \\times C_{ACh}$, the inward current remains suppressed and does not recover to $I_{max}$. When applied alone, Drug Y also produces no measurable current.\n\nBased on these experimental results, which of the following statements most accurately describes the binding sites and mechanisms of action for Drug X and Drug Y?\n\nA. Drug X is a competitive antagonist that binds within the ion pore, while Drug Y is a non-competitive antagonist that binds to the ACh binding site.\n\nB. Drug X is a non-competitive antagonist that binds to the ACh binding site, while Drug Y is a competitive antagonist that binds within the ion pore.\n\nC. Drug X is a competitive antagonist that binds to the ACh binding site, while Drug Y is a non-competitive antagonist that likely acts as a pore blocker.\n\nD. Drug X and Drug Y are both competitive antagonists, but Drug Y has a much higher affinity for the ACh binding site.\n\nE. Drug X is a non-competitive antagonist that likely acts as a pore blocker, while Drug Y is a competitive antagonist that binds to the ACh binding site.", "solution": "We interpret the inward current through nicotinic acetylcholine receptors (nAChRs) under whole-cell patch clamp as a function of receptor activation by acetylcholine (ACh) and modulation by antagonists. Let $[A]$ denote the agonist (ACh) concentration, $I_{max}$ the maximal achievable current in control, and $I$ the measured current.\n\nFor competitive antagonism at the ACh binding (orthosteric) site, the standard receptor occupancy/dose-response relationship with a reversible antagonist $X$ at concentration $[X]$ and equilibrium dissociation constant $K_{X}$ is\n$$\nI([A],[X])=I_{max}\\,\\frac{[A]}{[A]+K_{A}\\left(1+\\frac{[X]}{K_{X}}\\right)},\n$$\nwhere $K_{A}$ is the agonist dissociation constant. This yields two characteristic predictions:\n- Surmountability: as $[A]\\to \\infty$, $I([A],[X])\\to I_{max}$ regardless of $[X]$, so the maximal response is recoverable at sufficiently high $[A]$.\n- No intrinsic efficacy: with $[A]=0$, $I(0,[X])=0$.\n\nFor non-competitive antagonism (e.g., channel pore blockade or negative allosteric modulation of efficacy), the antagonist reduces the effective maximal response without shifting the agonist $EC_{50}$ in a strictly competitive manner. A simple form capturing this is\n$$\nI([A],[Y])=\\alpha([Y])\\,I_{max}\\,\\frac{[A]}{[A]+K_{A}},\n$$\nwith $0<\\alpha([Y])<1$ determined by $[Y]$ and its binding constant. This is characterized by:\n- Insurmountability: even as $[A]\\to \\infty$, the current saturates at $\\alpha([Y])\\,I_{max}<I_{max}$, so increasing $[A]$ cannot restore $I_{max}$.\n- No intrinsic efficacy: with $[A]=0$, $I(0,[Y])=0$.\n\nNow match to observations:\n1. Control: $[A]=C_{ACh}$ produces $I_{max}$, consistent with $C_{ACh}$ near the saturating regime for this preparation.\n\n2. Drug X trial: At $[A]=C_{ACh}$, the current is less than $I_{max}$; however, raising $[A]$ to $100\\times C_{ACh}$ restores the current to $I_{max}$. This is the hallmark of surmountable antagonism, described by the competitive model above. Additionally, Drug X alone produces no current (no intrinsic efficacy), consistent with an antagonist. Therefore, Drug X is a competitive antagonist at the ACh binding site (orthosteric). Binding within the ion pore would not be competitive with ACh (since the pore and orthosteric sites are distinct) and typically yields insurmountable block.\n\n3. Drug Y trial: At $[A]=C_{ACh}$, current is reduced; even at $[A]=100\\times C_{ACh}$, the current remains suppressed and does not recover to $I_{max}$. This is the hallmark of insurmountable antagonism, well described by a non-competitive mechanism that reduces $I_{max}$, such as open-channel pore blockade or negative allosteric modulation of efficacy. Drug Y alone produces no current, consistent with antagonist behavior without agonism.\n\nEliminating distractors:\n- Statements placing a competitive antagonist in the ion pore (A and B) are inconsistent with the definition of competitive antagonism at the orthosteric ACh site.\n- Claiming both are competitive with Drug Y merely having higher affinity (D) is inconsistent with the observed insurmountability; even very high affinity competitive antagonism remains surmountable in principle by sufficiently high $[A]$.\n- Reversing the roles (E) contradicts the surmountability profile observed.\n\nTherefore, the correct description is that Drug X is a competitive antagonist at the ACh binding site, while Drug Y is a non-competitive antagonist likely acting as a pore blocker.\n\nHence, option C is correct.", "answer": "$$\\boxed{C}$$", "id": "2346549"}]}